May 13, 2021Anavex Life Sciences Reports Fiscal 2021 Second Quarter Financial Results And Business Outlook
May 7, 2021Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit
May 6, 2021Anavex Life Sciences to Announce Fiscal 2021 2nd Quarter Financial Results and Business Outlook
Apr 26, 2021Anavex Life Sciences to Present at the B. Riley Securities’ Virtual Neuroscience Conference
Apr 7, 2021Anavex Life Sciences Announces Participation at World EPA – Evidence, Pricing and Access Congress
Feb 19, 2021Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit
Feb 18, 2021Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Feb 11, 2021Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook
Feb 8, 2021Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook
Jan 11, 2021Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73
Dec 28, 2020Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates
Dec 22, 2020Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020
Dec 21, 2020Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX®2-73 (Blarcamesine) Phase 2 Data
